Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2016

Mar 1, 2016

5262_dirs_2016-03-01_ab894b55-1052-4a69-acec-47f5f2475659.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6671Q

GlaxoSmithKline PLC

01 March 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

Vesting of conditional share awards under the

GlaxoSmithKline Share Value Plan

This notification sets out the vesting of an award over American Depositary Shares (ADS) in GlaxoSmithKline plc, made in 2013 under the GlaxoSmithKline Share Value Plan (SVP), which was conditional on continued employment with the GlaxoSmithKline group.

The restricted period for the 2013 SVP awards has now ended and the award made to the connected person of a Person Discharging Managerial Responsibility (PDMR) vested on 28 February 2016.  Details are given in the table below.

Name of

Director / PDMR
Name of connected person Number of ADS  vested
Dr M Slaoui* Dr K Slaoui 2,990

* Denotes an Executive Director

The Company and the above individual were advised of this transaction on 29 February 2016.

The closing price of an ADS of GlaxoSmithKline plc on 26 February 2015, the business day prior to vesting, was US$39.14.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).

V A Whyte

Company Secretary

1 March 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSZFLFBQXFXBBL